14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 18 Jun 2024

Trading levels for NOX.AX

Fibonacci Support & Resistance Levels

Level Price
R3 0.0777 15.92%
R2 0.0746 11.36%
R1 0.0727 8.54%
Price 0.0670
S1 0.0666 -0.581%
S2 0.0647 -3.40%
S3 0.0617 -7.96%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0780 16.42%
R2 0.0720 7.46%
R1 0.0710 5.97%
Price 0.0670
S1 0.0650 -2.99%
S2 0.0630 -5.97%
S3 0.0600 -10.45%

NOX.AX Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Noxopharm Limited

Noxopharm Limited Noxopharm Limited, a drug development company, engages in the research and development of drugs for the treatment of cancer and prevention of septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate ca... NOX.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT